Healthcare - Biotechnology - NASDAQ - DK
$ 126.51
1.79 %
$ 7.26 B
Market Cap
-13.89
P/E
Price Target
Average
54.56%
Revenue Forecast
Estimate
72.40%
EBIT
Estimate
--50.81%
Net Income
Estimate
37.75%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Ascendis Pharma A/S
Wall Street analysts predict an average 1-year price target for ASND of $196 , with forecasts ranging from a low of $140 to a high of $289 .
ASND Lowest Price Target
Wall Street Target
140 USD
10.66%
ASND Average Price Target
Wall Street Target
196 USD
54.56%
ASND Highest Price Target
Wall Street Target
289 USD
128.44%
REVENUE FORECAST
Revenue Forecast Chart ASND
EBIT FORECAST
EBIT Forecast Chart ASND
NET INCOME FORECAST
Net Income Chart ASND